| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 122.58 | -1.06 (-0.86%) | 58.53 - 131.82 | 2.3 million (Below Avg) |
Market data as of 4:00PM 05/24/13. Quotes are delayed by at least 15 min.
Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA in Advanced Pancreatic Cancer
05/23/2013 7:30 AM ET
Acceleron’s ACE-536 Preclinical Data Presentation Selected for Best Abstract at 12th International Symposium on Myelodysplastic Syndromes
05/10/2013 8:15 AM ET
Apremilast Achieves Statistical Significance for the Primary and Major Secondary Endpoints in Fourth Pivotal Phase III Study (PALACE 4) of Patients with Psoriatic Arthritis
05/06/2013 2:27 PM ET